Allos Therapeutics Inc - Current report filing (8-K)
20 6월 2008 - 9:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of
The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 20, 2008 (June 16, 2008)
ALLOS
THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
|
000-29815
|
|
54-1655029
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
|
|
|
|
|
11080 CirclePoint Road, Suite 200
Westminster, Colorado
|
|
80020
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants
telephone number, including area code:
(303)
426-6262
Not applicable
(Former
name or former address, if changed since last report.)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see
General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
INFORMATION TO BE INCLUDED IN THE REPORT
Section 1 Registrants Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
On June 16, 2008, Allos Therapeutics, Inc.
(the Company) entered into a Fifth Amendment to Office Lease Agreement (the Fifth
Lease Amendment) to its Office Lease, dated April 4, 2001, as previously
amended (the Existing Lease Agreement), with Circle Point Properties, LLC (Landlord),
successor to Catellus Development Corporation.
The Existing Lease Agreement, as amended by the Fifth Lease Amendment is
hereinafter referred to as the Lease Agreement.
Pursuant to the Fifth Lease Amendment, the Company and
Landlord agreed to extend the term of the Lease Agreement from and after November 1,
2008 for a period of thirty-nine (39) months to expire January 31,
2012. The parties also agreed that the
Company will have the right, subject to the terms of the Fifth Lease Amendment,
to extend the term of the Lease Agreement for one (1) additional period of
three (3) years thereafter.
Under the Fifth Lease Amendment, the Company and
Landlord further agreed to reduce the number of rentable square feet included
in the leased premises to approximately 34,536 square feet. The premises leased under the Lease Agreement
is the premises commonly known as Suite 200, Suite 160 and storage
space located in the office building located at 11080 Circle Point Road,
Westminster, Colorado 80020.
Except as provided in the Fifth Lease Amendment, all
other terms of the Existing Lease Agreement remain in full force and effect.
The Company will file the
Fifth
Lease Amendment as an exhibit to its Form 10-Q
for the quarter ended June 30, 2008.
2
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 20,
2008
|
|
|
|
|
|
|
|
|
|
|
ALLOS THERAPEUTICS, INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Marc H. Graboyes
|
|
|
Marc H. Graboyes
|
|
Its:
|
Senior Vice President,
General Counsel & Secretary
|
3
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
과거 데이터 주식 차트
부터 7월(7) 2024 으로 8월(8) 2024
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
과거 데이터 주식 차트
부터 8월(8) 2023 으로 8월(8) 2024